York helps to lead research to advance diabetes drug to clinical trials
Zucara Therapeutics secures US$3.9 million from the Helmsley Charitable Trust to advance a diabetes drug candidate to clinical trials, with research taking place at York University by Professor Michael Riddell.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
